Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	PRIMARY OBJECTIVE <br/ >To assess the Efficacy of single dose of Ivermectin; given within first 5 days of symptom onset; as assessed by RT PCR for SARS CoV 2; at 3rd and 7th day after start of treatmentTimepoint: At Admission; 3rd and 7th Day after start of treatment <br/ >	PRIMARY OBJECTIVE <br/ >To assess the Efficacy of single dose of Ivermectin; given within first 5 days of symptom onset; as assessed by RT PCR for SARS CoV 2; at 3rd and 7th day after start of treatmentTimepoint: At Admission; 3rd and 7th Day after start of treatment <br/ >
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Oct. 26, 2020, 8:29 a.m.	oms	PRIMARY OBJECTIVE <br/ >To assess the Efficacy of single dose of Ivermectin; given within first 5 days of symptom onset; as assessed by RT PCR for SARS CoV 2; at 3rd and 7th day after start of treatmentTimepoint: At Admission; 3rd and 7th Day after start of treatment <br/ >	PRIMARY OBJECTIVE <br/ >To assess the Efficacy of single dose of Ivermectin; given within first 5 days of symptom onset; as assessed by RT PCR for SARS CoV 2; at 3rd and 7th day after start of treatmentTimepoint: At Admission; 3rd and 7th Day after start of treatment <br/ >